Cogstate tasks, including the Cogstate Brief Battery™, have been included in published studies across various indications.
Use the fields on the left to search specific areas of interest, including sensitivity in Alzheimer’s disease, Depression, Concussion/Athletes, AIDS/HIV, Schizophrenia, ADHD and Alcohol; as well as properties, demographic features and cultural validity.
A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort.
Alzheimer’s Disease (AD) is the most common form of dementia, characterised by extracellular amyloid deposition as plaques and intracellular neurofibrillary tangles of tau protein. As no current clinical test can diagnose individuals at risk of developing AD, the aim of this project is to evaluate a blood-based biomarker panel to identify individuals who carry this […]
Vortioxetine for major depressive disorder, vasomotor, and cognitive symptoms associated with the menopausal transition.
BACKGROUND: In a preliminary trial, we assessed the efficacy of vortioxetine for major depressive disorder (MDD) during the menopausal transition. Secondary outcomes included hot flashes (HFs), anxiety, and cognitive complaints. METHODS: Perimenopausal and early postmenopausal women with MDD (N = 27) received 8 weeks of open-label, flexible-dose treatment with vortioxetine. The Montgomery-Åsberg Depression Rating Scale […]
Sensitivity of the Cogstate Test Battery for Detecting Prolonged Cognitive Alterations Stemming From Sport-Related Concussions.
OBJECTIVE: To determine if the Cogstate test battery contains the requisite sensitivity to detect prolonged cognitive alterations. METHODS: One hundred twenty collegiate athletes (71 with a history of concussion; 49 controls) completed the Cogstate test battery, to which we added a 2-back condition. In addition to the Cogstate clinical (transformed variables), we analyzed the raw […]